Chinese American biologist Feng Zhang (張鋒), one of the three recipients of the Tang Prize in biopharmaceutical science, said the prize was recognition for his entire lab for its research on the CRISPR/Cas9 genome editing tool.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Garmin to invest in Southeast Asia to strengthen supply chain
04/26/2024 02:53 PM - Business
Taiwan shares close up 1.32%
04/26/2024 02:01 PM - Society
Heavy rain advisory issued for 11 cities and counties
04/26/2024 01:37 PM - Society
Taiwan headline news
04/26/2024 11:58 AM - Business
U.S. dollar down in Taipei trading
04/26/2024 10:39 AM